Free Trial

Medpace (MEDP) Stock Price, News & Analysis

Medpace logo
$447.49 -8.19 (-1.80%)
Closing price 04:00 PM Eastern
Extended Trading
$447.00 -0.49 (-0.11%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Medpace Stock (NASDAQ:MEDP)

Key Stats

Today's Range
$427.27
$449.78
50-Day Range
$293.03
$477.73
52-Week Range
$250.05
$501.30
Volume
763,602 shs
Average Volume
683,834 shs
Market Capitalization
$12.57 billion
P/E Ratio
33.27
Dividend Yield
N/A
Price Target
$411.10
Consensus Rating
Hold

Company Overview

Medpace Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

MEDP MarketRank™: 

Medpace scored higher than 74% of companies evaluated by MarketBeat, and ranked 282nd out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medpace has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 10 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Medpace has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Medpace's stock forecast and price target.
  • Earnings Growth

    Earnings for Medpace are expected to grow by 11.15% in the coming year, from $12.29 to $13.66 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medpace is 33.27, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.91.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medpace is 33.27, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.11.

  • Price to Earnings Growth Ratio

    Medpace has a PEG Ratio of 7.96. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Medpace has a P/B Ratio of 72.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    14.02% of the float of Medpace has been sold short.
  • Short Interest Ratio / Days to Cover

    Medpace has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Medpace has recently increased by 5.83%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Medpace does not currently pay a dividend.

  • Dividend Growth

    Medpace does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.02% of the float of Medpace has been sold short.
  • Short Interest Ratio / Days to Cover

    Medpace has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Medpace has recently increased by 5.83%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Medpace has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.06 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 40 news articles for Medpace this week, compared to 12 articles on an average week.
  • Search Interest

    12 people have searched for MEDP on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medpace insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.30% of the stock of Medpace is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    77.98% of the stock of Medpace is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Medpace's insider trading history.
Receive MEDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medpace and its competitors with MarketBeat's FREE daily newsletter.

MEDP Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Medpace Holdings, Inc. (MEDP) Stock Forecasts
Medpace Holdings, Inc. (MEDP): A Bull Case Theory
Medpace (NASDAQ:MEDP) Shares Gap Up Following Earnings Beat
Medpace Beats Q2 Revenue Estimates
See More Headlines

MEDP Stock Analysis - Frequently Asked Questions

Medpace's stock was trading at $332.23 at the start of the year. Since then, MEDP shares have increased by 34.7% and is now trading at $447.49.

Medpace Holdings, Inc. (NASDAQ:MEDP) posted its earnings results on Monday, July, 21st. The company reported $3.10 earnings per share for the quarter, topping the consensus estimate of $3.00 by $0.10. The firm's revenue was up 14.2% compared to the same quarter last year.
Read the conference call transcript
.

Medpace (MEDP) raised $150 million in an initial public offering on Thursday, August 11th 2016. The company issued 7,000,000 shares at $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.

Medpace's top institutional investors include Riverbridge Partners LLC (1.51%), Annex Advisory Services LLC (0.33%), Argent Capital Management LLC (0.28%) and Swedbank AB (0.25%). Insiders that own company stock include Medpace Investors, Llc, August J Troendle, Susan E Burwig, Stephen P Ewald, Kevin M Brady, Fred B Davenport Jr, Ashley M Keating and Robert O Kraft.
View institutional ownership trends
.

Shares of MEDP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medpace investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), McKesson (MCK), Arista Networks (ANET), Adobe (ADBE) and ServiceNow (NOW).

Company Calendar

Last Earnings
7/21/2025
Today
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:MEDP
CIK
1668397
Employees
5,900
Year Founded
N/A

Price Target and Rating

High Price Target
$510.00
Low Price Target
$330.00
Potential Upside/Downside
-8.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$13.45
Trailing P/E Ratio
33.27
Forward P/E Ratio
36.41
P/E Growth
7.96
Net Income
$404.39 million
Net Margins
18.74%
Pretax Margin
22.20%
Return on Equity
67.66%
Return on Assets
21.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.43
Quick Ratio
0.73

Sales & Book Value

Annual Sales
$2.23 billion
Price / Sales
5.76
Cash Flow
$14.27 per share
Price / Cash Flow
31.35
Book Value
$6.14 per share
Price / Book
72.88

Miscellaneous

Outstanding Shares
28,742,000
Free Float
22,907,000
Market Cap
$12.86 billion
Optionable
Optionable
Beta
1.47

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:MEDP) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners